StageZero Life Sciences (GNWSD) Short Interest Ratio & Short Volume

Short interest is the volume of StageZero Life Sciences shares that have been sold short but have not yet been closed out or covered. As of September 30th, traders have sold 51,300 shares of GNWSD short. Learn More on StageZero Life Sciences' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GNWSD shares currently have a short interest ratio of 5.0. Learn More on StageZero Life Sciences's short interest ratio.

StageZero Life Sciences saw a decline in short interest in September. As of September 30th, there was short interest totaling 51,300 shares, a decline of 36.6% from the previous total of 80,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to StageZero Life Sciences: Comera Life Sciences Holdings, Inc. (2.38%), Vyant Bio, Inc. (0.67%), SQZ Biotechnologies (0.09%), Global Roundtable Co. (0.00%), Panbela Therapeutics, Inc. (2.36%), GRI Bio, Inc. (1.81%), Remedent, Inc. (0.00%), 180 Life Sciences Corp. (8.36%), Virax Biolabs Group Limited (0.17%), GlobeStar Therapeutics Co. (0.01%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.91 billion), Aon plc ($3.68 billion), The Clorox Company ($2.92 billion), Analog Devices, Inc. ($2.35 billion), Uber Technologies, Inc. ($2.27 billion), Moderna, Inc. ($2.14 billion), The Kroger Co. ($2.14 billion), Datadog, Inc. ($2.00 billion), Simon Property Group, Inc. ($1.85 billion), and International Flavors & Fragrances Inc. ($1.75 billion). View all of the most shorted stocks.

Short selling GNWSD is an investing strategy that aims to generate trading profit from StageZero Life Sciences as its price is falling. GNWSD shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for StageZero Life Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GNWSD, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNWSD, twice per month. The most recent reporting period available is September, 30 2020.